vimarsana.com

Latest Breaking News On - Dwight gorham - Page 3 : vimarsana.com

IntelGenx to Report Third Quarter 2023 Financial Results on November 9, 2023 – Conference Call to Follow

IntelGenx to Report Third Quarter 2023 Financial Results on November 9, 2023 – Conference Call to Follow
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Saint-laurent
Quebec
Canada
United-states
Canadian
Andre-godin
Stephen-kilmer
Horstg-zerbe
Dwight-gorham
Securities-exchange
Exchange-commission
Intelgenx-technologies-corp

IntelGenx to Report Third Quarter 2023 Financial Results on

SAINT LAURENT, Quebec, Nov. 02, 2023 (GLOBE NEWSWIRE) IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical.

United-states
Quebec
Canada
Saint-laurent
Canadian
Andre-godin
Stephen-kilmer
Horstg-zerbe
Dwight-gorham
Securities-exchange
Intelgenx-corp
Exchange-commission

IntelGenx to Report Third Quarter 2023 Financial Results on November 9, 2023 – Conference Call to Follow

IntelGenx to Report Third Quarter 2023 Financial Results on November 9, 2023 – Conference Call to Follow
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Quebec
Canada
Saint-laurent
Canadian
Dwight-gorham
Andre-godin
Horstg-zerbe
Securities-exchange
Exchange-commission
Intelgenx-technologies-corp
Cfointelgenx-corp

IntelGenx Provides RIZAFILM® U.S. Commercialization Update

Receives first purchase order from Gensco® PharmaSAINT LAURENT, Quebec, Sept. 21, 2023 IntelGenx Corp. today announced that it has received the first purchase order for RIZAFILM®1 from its.

Canada
Saint-laurent
Quebec
United-states
Canadian
American
Americans
Stephen-kilmer
Gensco-pharma
Dwight-gorham
Andre-godin
Paul-zimmerman

IntelGenx Provides Regulatory Update for Xiromed-Partnered Development Candidate, Buprenorphine Buccal Film

SAINT LAURENT, Quebec, Sept. 19, 2023 IntelGenx Corp. today provided a regulatory update on Buprenorphine Buccal Film, for which an abbreviated new drug application has been filed with the.

Quebec
Canada
Madrid
Spain
Saint-laurent
United-states
Canadian
Andre-godin
Insud-pharma
Intelgenx-versafilm
Stephen-kilmer
Dwight-gorham

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.